CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction

David M Charytan1, Noam M Stern, Laura Mauri

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02120, USA. dcharytan@partners.org

Insights

Chronic kidney disease (CKD) patients do not show diminished coronary collateral supply after myocardial infarction (MI). This study found no significant difference in collateral function between CKD and non-CKD patients, suggesting other factors contribute to higher MI risks.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Background:

  • Patients with chronic kidney disease (CKD) face elevated mortality risks following myocardial infarction (MI).
  • Adequate coronary collateral supply is linked to better outcomes post-MI.
  • The role of collateral supply in CKD patients' increased MI risk remains unclear.

Purpose of the Study:

  • To investigate whether diminished coronary collateral supply contributes to the heightened mortality risk observed in CKD patients after MI.
  • To compare collateral supply in the culprit artery between CKD and non-CKD patients undergoing coronary angiography during MI.

Main Methods:

  • Quantitative coronary angiography was used to assess collateral supply in 58 CKD patients and 165 individuals without CKD at the time of MI.
  • Logistic regression and ordered categorical regression models were employed to analyze collateral supply and predictors.

Main Results:

  • No significant differences in collateral supply were found between CKD patients and individuals with preserved renal function.
  • The prevalence of culprit artery collaterals was similar (25.0% vs. 27.2%, P=0.76).
  • CKD was not independently associated with diminished collateral supply to culprit or nonculprit vessels after adjusting for confounders.

Conclusions:

  • The study does not support an independent association between CKD and reduced collateral supply to coronary vessels in the context of MI.
  • Further research is needed to clarify the relationship between CKD, myocardial capillary supply, collateral function, and overall cardiovascular outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...